InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,700.00
(
-0.02%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
78.70
(
0.00%
)
Bitcoin
62,673.19
(
-0.82%
)

Replies to post #25752 on PharmaCyte Biotech Inc (PMCB)

Replies to #25752 on PharmaCyte Biotech Inc (PMCB)
icon url

bulldurham

09/02/14 10:36 AM

#25756 RE: bulldurham #25752

Nuvilex coming to fruition...EU application done...then Australia...then the U.S.

go Nuvilex
bull
icon url

bulldurham

09/02/14 1:44 PM

#25785 RE: bulldurham #25752

Nuvilex with Orphan Drug Status ... Once a
compound has been granted orphan designation, the odds for approval are high (82%) compared to traditional drugs (35%)... and orphan designation for the drug in the orphan indication is maintained regardless of follow-on indications...also one model for development is based on lead development of a compound with a relatively quick-to-market orphan indication, followed by consideration of expansion to other indications....

bull